Most Read Articles
Elaine Soliven, 3 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Stephen Padilla, 3 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 2 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.

MHealth HIV prevention programme acceptable for boys in the sexual minority

01 Sep 2019
Uses of smartphone and interaction on social media could be analysed to predict when a patient is likely to suffer from mental illnesses.

Guy2Guy, an mHealth HIV prevention programme, is acceptable and feasible for use in young, sexual minority boys, reports a recent study.

Researchers randomly assigned 302 sexual minority boys to receive the Guy2Guy mHealth intervention or an attention-matched control scenario. An online survey about feasibility and acceptability was administered at 3 months, and a subsequent focus group consultation was performed.

After 3 months, 283 participants remained enrolled, resulting in a retention rate of 94 percent. This was greater than the 80-percent threshold, indicating good feasibility of the mHealth intervention.

The online survey was completed by 275 participants, while 16 accomplished the text message-based survey. Results showed that the mHealth intervention was both acceptable and tolerable. For instance, 93 percent somewhat or strongly agreed that they liked the programme, while 75 percent said that they were very likely or somewhat inclined to recommend Guy2Guy to their peers.

On the other hand, while more than 90 percent participants responded that the messages were easy enough to comprehend, 22 percent and 10 percent agreed that the intervention focused too much on condoms and HIV and other sexually-transmitted diseases, respectively.

Moreover, 20 percent respondents felt that the Guy2Guy programme sent too many messages, though only 10 percent admitted that they stopped reading the messages toward the end of the programme. Five percent said that the programme disrupted their daily schedule.

“Although the evidence for text messages to impact behaviours is increasingly strong, we still lack the precise knowledge of how to design engaging content, how to calibrate dose and timing of messages, and whether a specific dose is needed to achieve or increase targeted behavioural outcomes,” said researchers. Future studies should focus on addressing these gaps.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 3 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Stephen Padilla, 3 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 2 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.